Brainstorm Cell Therapeutics | BCLI - Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Biogen USD 29.48B 43.6M 2026-03
Brainstorm Cell Therapeutics USD 1.02M 358K 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.27B 151.06M 2026-03
Gilead Sciences USD 59.02B 490M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Mesoblast USD 782.31M 2.38M 2025-12